NVO vs BMY
Novo Nordisk A/S vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | NVO | BMY |
|---|---|---|
| AI Score | 56 | 60 |
| Price | $49.48 | $57.56 |
| P/E Ratio | 11.75× | 19.93× |
| ROE | 66.4% | 41.6% |
| Revenue Growth YoY | 8.1% | 1.8% |
| Gross Margin | 81.8% | 53.7% |
| Debt / Equity | 0.67× | 2.44× |
| Dividend Yield | 3.7% | 4.3% |
| RSI (14) | 65.6 | 53.8 |
| Beta | 1.8569 | 0.235 |
| Expected Upside | +25.9% | +4.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NVO Full Analysis
BMY Full Analysis